Why low income countries are so short on COVID vaccines. Hint: It's not boosters
Wealthy countries keep buying way more doses than they need. New data shows just how much the stockpile of unused vaccine is growing.
Global Health
How SARS-CoV-2 in American deer could alter the course of the global pandemic
Scientists have evidence that SARS-CoV-2 is circulating in white-tailed deer in the U.S. They say the findings could essentially dash any hopes of eliminating the virus in the U.S. — and the world.
They're the invisible victims of climate change
At summits like COP26, attention is paid to those who find their livelihood — and health — at risk and who might become climate change refugees. But who will speak up for the stateless?
Filipino American health workers reflect on trauma and healing on COVID's frontlines
They have shouldered an outsize share of COVID-19's burden, statistics show. Many lost family members; others got sick themselves, recovered and carried on. Meet the caregivers.
New coronavirus, likely from dogs, infects people in Malaysia and Haiti
It could turn out to be the eighth coronavirus known to spread to humans. Some scientists think doctors and researchers should start actively looking for this virus in patients.
Low income nations need COVID vaccines. Rich countries have millions of unused doses
There's been a massive ramp up in production of COVID-19 vaccines. Yet low income nations still aren't getting enough. Analysts say it's because wealthy countries are buying way more than they need.
These 4 college freshmen from India have a remarkable story to tell
They came from families that have faced seemingly insurmountable hardships and were admitted by top U.S. colleges. A school in India gave them their chance.
Coronavirus FAQ: It's cold and flu season — and COVID season! How do I stay unsick?
Last winter the number of flu cases was pretty low — likely a result of COVID precautions people were taking. Does that mean we have fewer antibodies — and a greater risk of catching something now?
Pfizer says its COVID-19 pill cuts disease's worst risks by 89%
Based on the strength of the trial's results, Pfizer says it will ask the FDA for emergency use authorization rather than enroll more people for clinical trials.
One Chinese town has started a fiery online debate about China's zero-COVID policy
Citizens in Ruili are complaining about lengthy lockdowns and terrible conditions in quarantine centers. Others in China don't want to hear about it.